Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01319643Phase 4Unknown
Phase 4, randomised, open-label trial of oxygen in critical illness (2 arms), sponsored by University of Modena and Reggio Emilia. Primary endpoint: Mortality in Intensive Care Unit at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01319643.